Monmouth Junction, NJ and Tokyo, Japan — January 7, 2026 — TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth factors, today announced that the two companies have entered into a Marketing Collaboration Agreement to jointly promote cutting-edge solutions for stem cell culture, organoid development, and cell therapy manufacturing. [Read more…]
How Long Does It Take for Stem Cell Therapy to Work?
Are you considering having stem cell therapy? If so, you’re probably wondering, how long does it take for stem cell therapy to work?
In this article, we will go over what stem cell therapy is, how the various procedures work, and what to expect post stem cell treatment. It’s important to know that extremely few stem cell procedures are FDA approved, so you will need to do your due diligence.
Keep reading to get informed on this topic. [Read more…]
PeptiGrowth Inc. is Launching a Novel Synthetic Peptide: IL-15 alternative peptide
January 6, 2026, Chiyoda-ku, Tokyo — PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Jun Minamitani) has successfully developed a novel synthetic peptide called “IL-15 alternative peptide” which is functionally equivalent to recombinant interleukin 15 (IL-15). This product will be on the market in December 2025. [Read more…]
How To (Potentially) Avoid Back Pain Surgery with Stem Cells
According to the National Institute of Neurological Disorders and Stroke, 80% of Americans will have at least one episode of lower (or lumbar) back pain in their lifetimes. Discomfort or pain in the cervical and thoracic regions is common as well, with an estimated one-third of Americans living with pain at any given time. For much of human history, back pain treatment consisted of home remedies, massage, cold and heat therapies, and rest – but not much more.
In this article:
Induced Pluripotent Stem Cell (iPSC) Industry Trends Dominating in 2026
Induced pluripotent stem cells (iPS cells or iPSCs) are laboratory-made pluripotent stem cells that are produced using non-controversial adult cells. They are derived from somatic cells through reprogramming and turning on the expression of specific pluripotency genes. This reprogramming can be achieved using different techniques with varying efficiencies. [Read more…]
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 338
- Next Page »